About Core Diagnostics
Core Diagnostics is a company based in Gurugram (India) founded in 2012 was acquired by Metropolis India in December 2024. It operates as a Subscription Services and HealthTech. Core Diagnostics has raised $17.26 million across 2 funding rounds from investors including Metropolis India, Eight Roads Ventures and F-Prime Capital. The company has 496 employees as of April 07, 2024. Core Diagnostics offers products and services including High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans. Core Diagnostics operates in a competitive market with competitors including Roche, Healthians, Quest Diagnostics, Agappe and LumiraDx, among others.
- Headquarter Gurugram, India
- Employees 496 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Core Diagnostics
- Date of Incorporation 28 Jun, 2012
- Jurisdiction Gurugram, Haryana, India
-
Annual Revenue
$11.27 M (USD)-10.79as on Mar 31, 2023
-
Net Profit
-$1.54 M (USD)-1418.31as on Mar 31, 2023
-
EBITDA
-$1.33 M (USD)-1054.48as on Mar 31, 2023
-
Total Equity Funding
$17.26 M (USD)
in 2 rounds
-
Latest Funding Round
$12.26 M (USD), Series B
Dec 01, 2016
-
Investors
Metropolis India
& 3 more
-
Employee Count
496
as on Apr 07, 2024
-
Acquired by
Metropolis India
(Dec 09, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Core Diagnostics
Core Diagnostics offers a comprehensive portfolio of products and services, including High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans.
Advanced diagnostic tests for various medical conditions are provided.
Genetic tests for cardiovascular and endocrine disorders are offered.
Subscription plans for diabetes and hypertension management are available.
People of Core Diagnostics
Unlock access to complete
Funding Insights of Core Diagnostics
Core Diagnostics has successfully raised a total of $17.26M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.26 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Core Diagnostics
Core Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Metropolis India, Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in technology and healthcare sectors.
|
Locked | Locked | Locked |
Investor details for Core Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Core Diagnostics
Investment portfolio details for Core Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Core Diagnostics
Detailed financials for Core Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Core Diagnostics Comparisons
Peer comparison for Core Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Core Diagnostics
Core Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, Healthians, Quest Diagnostics, Agappe and LumiraDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Online platform for at home diagnostic tests and health checkups
|
|
| Locked | Locked | Locked |
Integrated diagnostic and IT services are provided to healthcare organizations.
|
|
| Locked | Locked | Locked |
In-vitro diagnostic reagents and equipment are manufactured and distributed.
|
|
| Locked | Locked | Locked |
Cloud based diagnostics platform for point of care diagnosing
|
|
| Locked | Locked | Locked |
Diagnostic company specializing in the manufacture of in-vitro diagnostic instruments and solutions
|
Detailed competitors of Core Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Core Diagnostics
Complete news archive for Core Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Core Diagnostics
Core Diagnostics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Core Diagnostics is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Dinesh Chauhan is the current CEO of Core Diagnostics.
Core Diagnostics is a funded company, having raised a total of $17.26M across 2 funding rounds to date.
As of Apr 07, 2024, the latest employee count at Core Diagnostics is 496.
Annual revenue of Core Diagnostics is $11.27M as on Mar 31, 2023.
Core Diagnostics is established as a premier diagnostic center in India, specializing in high-end diagnostic solutions. Services are provided across a wide range of medical fields including hereditary and sporadic cancers, hematological disorders, reproductive health, cardiovascular diseases, kidney diseases, urological disorders, ophthalmologic conditions, and neurological disorders. Advanced technologies such as molecular testing, immunohistochemistry, flow cytometry, histopathology, cytopathology, and cytogenetics are utilized to ensure precise and comprehensive diagnostic outcomes. The company is trusted by numerous doctors and has impacted many patient lives through innovative diagnostic approaches.
Core Diagnostics's top competitors include Roche, Healthians and Quest Diagnostics.
Core Diagnostics offers High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans.
Core Diagnostics has 4 investors. Key investors include Metropolis India, Eight Roads Ventures, F-Prime Capital, and Artiman.